Sep 8, 2023, 08:59 by

Sep 8, 2023, 08:59 by

Sep 8, 2023, 01:00 by User Not Found

Clinical Research News | As experimental drugs to treat Alzheimer’s disease increasingly target the disease’s very initial stages, monitoring the impact of novel treatments on cognition has become a complex undertaking for trial sponsors.

Sep 6, 2023, 14:47 by

iotaSciences and Quantum Design China announced today an exclusive distribution agreement for iotaSciences proprietary single cell handling platforms in China.

Sep 6, 2023, 14:47 by

Dr. Vince Clinical Research (DVCR), a full-service clinical research organization (CRO), today announced the first dosing in Cingulate Therapeutics’ CTx-1301 Phase III dose-optimization onset and duration laboratory classroom study.

Sep 6, 2023, 14:47 by

About Recipharm Recipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical and biopharmaceutical industry employing almost 9,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, pharmaceutical and biologics product development, and development and manufacturing of medical devices. Recipharm manufactures several hundred different products for customers ranging from big pharma to smaller research and development companies. The company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK, and the US and is headquartered in Stockholm, Sweden. For more information on Recipharm and our services, please visit www.recipharm.com About Ahead Therapeutics Ahead Therapeutics is a start-up biotech company that uses proprietary technology to develop treatments for different autoimmune disorders. Ahead Therapeutics has developed an innovative solution based on the use of PS-liposomes containing autoantigens. These liposomes can induce antigen-specific immune tolerance through a biomimetic process, thereby interrupting the autoimmune reaction. Simply by changing the encapsulated autoantigen, Ahead’s technology can address the treatment of different auto-immune diseases: Type 1 Diabetes; Multiple Sclerosis; and Celiac Diseases, among others. For more information, please visit www.aheadtherapeutics.com Recipharm AB Corporate identity number 556498-8425 Address Box 603, SE-101 32 Stockholm, Sweden, Telephone +46 8 602 52 00 www.recipharm.com

Sep 6, 2023, 14:47 by

GenNext Technologies, Inc. has announced the release of the AutoFox Protein Footprinting System at the California Separation Science Society combined Mass Spectrometry and Higher Order Structure meetings.

Sep 6, 2023, 14:47 by

GenNext Technologies, Inc. has revealed their agreement to co-market a robust, full-solution workflow for Hydroxyl Radical Protein Footprinting studies with SCIEX.

Sep 5, 2023, 01:00 by User Not Found

Clinical Research News | When Dr. Caroline Fife stepped into her first clinical trial in 1997, she was met with a waiting room packed with patients. Despite the large number of potential participants, none of them were considered healthy enough for the clinical trial. That was when she realized something was very wrong.

Aug 31, 2023, 01:00 by User Not Found

Clinical Research News | Phastar appoints a new CEO amid organization changes and growth plans; Celltrion opens a Global R&D Center in South Korea for research capabilities and technologies spanning all areas of biopharmaceutics; Clario and AliveCor, Standigm and Nashville Biosciences, C2i Genomics and the Tel Aviv Sourasky Medical Center (Ichilov) announce partnerships; more.

Aug 30, 2023, 09:07 by

Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, has added Amir Lahav, a clinical leader and established neuroscientist with 20 years of experience to its advisory board.

Aug 30, 2023, 09:07 by

Aug 30, 2023, 09:07 by

Aug 30, 2023, 09:07 by

Dr. Vince Clinical Research (DVCR), an early phase Clinical Research Organization (CRO), today announced a new collaboration with Clario, a leading healthcare research and technology company that delivers leading endpoint technology solutions for clinical trials.

Aug 30, 2023, 09:07 by

Elligo Health Research®, the largest healthcare-enabling research organization, today announced the addition of Barry Simms as Elligo’s Chief Operating Officer (COO). Simms’ expertise in global strategy and partnerships will help further the company’s growth and mission of providing everyone with easy access to participation in research and to accelerate clinical trials along the way.

Aug 30, 2023, 09:07 by

Aug 30, 2023, 01:00 by User Not Found

Clinical Research News | Novo Nordisk acquires Inversago Pharma and the development of an appetite regulator; ADARx Pharmaceuticals will advance clinical programs on a rare genetic disease with new funding; Kriya Therapeutics plans to use Series C funding for clinical translation of gene therapies; more.

Aug 29, 2023, 09:05 by

Aug 24, 2023, 09:05 by

Kiora Pharmaceuticals, a clinical-stage biotechnology company developing products for the treatment of orphan retinal diseases, has been granted U.S. and European Patents for the local ocular delivery of the company’s non-steroidal, anti-inflammatory small molecules covering several inflammatory-related therapeutic applications including posterior non-infectious uveitis – a debilitating autoimmune disease characterized by inflammation of the retina, choroid, vitreous, or optic nerve that can lead to severe vision loss if left untreated.

Aug 24, 2023, 09:05 by

American Cancer Society's impact venture fund announces annual results and new framework that measures investments' impact on mission to end cancer